Crosstalk between NK cells and hepatic stellate cells in liver fibrosis

被引:26
作者
Zhang, Yang [1 ]
Wu, Yuan [2 ]
Shen, Wenjuan [3 ]
Wang, Bingyu [4 ,5 ]
Yuan, Xingxing [4 ,5 ]
机构
[1] Heilongjiang Univ Tradit Chinese Med, Dept Gastroenterol, Affiliated Hosp 1, Harbin 150001, Heilongjiang, Peoples R China
[2] Heilongjiang Univ Tradit Chinese Med, Grad Sch, Harbin 150001, Heilongjiang, Peoples R China
[3] Heilongjiang Univ Tradit Chinese Med, Dept Gynaecol, Affiliated Hosp 1, Harbin 150001, Heilongjiang, Peoples R China
[4] Heilongjiang Acad Tradit Chinese Med, Dept Gastroenterol, Harbin 150001, Heilongjiang, Peoples R China
[5] Heilongjiang Acad Tradit Chinese Med, Dept Gastroenterol, 33 West Dazhi St, Harbin 150001, Heilongjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
natural killer cells; fibrosis; hepatic stellate cells; crosstalk; TGF-beta; INJURY; INFLAMMATION; INHIBITION; ACTIVATION; SINUSOIDS; APOPTOSIS; PATHWAY; ROLES; TRAIL;
D O I
10.3892/mmr.2022.12724
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Liver fibrosis is a common pathological process of chronic liver diseases, including viral hepatitis and alcoholic liver disease, and ultimately progresses to irreversible cirrhosis and cancer. Hepatic stellate cells (HSCs) are activated to produce amounts of collagens in response to liver injury, thus triggering the initiation and progression of fibrogenesis. Natural killer (NK) cells serve as the essential component of hepatic innate immunity and are considered to alleviate fibrosis by killing activated HSCs. Current antifibrotic interventions have improved fibrosis, but fail to halt its progression in the advanced stage. Clarifying the interaction between NK cells and HSCs will provide clues to the pathogenesis and potential therapies for advanced liver fibrosis.
引用
收藏
页数:7
相关论文
共 70 条
[1]   Natural Killer Cell-Dependent Anti-Fibrotic Pathway in Liver Injury via Toll-Like Receptor-9 [J].
Abu-Tair, Lina ;
Axelrod, Jonathan H. ;
Doron, Sarit ;
Ovadya, Yossi ;
Krizhanovsky, Valery ;
Galun, Eithan ;
Amer, Johnny ;
Safadi, Rifaat .
PLOS ONE, 2013, 8 (12)
[2]   Hepatic Stellate Cells and Hepatocytes as Liver Antigen-Presenting Cells during B. abortus Infection [J].
Arriola Benitez, Paula Constanza ;
Pesce Viglietti, Ayelen Ivana ;
Mercedes Elizalde, Maria ;
Hernan Giambartolomei, Guillermo ;
Fabian Quarleri, Jorge ;
Victoria Delpino, Maria .
PATHOGENS, 2020, 9 (07) :1-14
[3]   Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy [J].
Cai, Xuanyan ;
Wang, Jiajia ;
Wang, Jincheng ;
Zhou, Qian ;
Yang, Bo ;
He, Qiaojun ;
Weng, Qinjie .
PHARMACOLOGICAL RESEARCH, 2020, 155
[4]   Egg antigen p40 of Schistosoma japonicum promotes senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway [J].
Chen, Jinling ;
Xu, Tianhua ;
Zhu, Dandan ;
Wang, Jianxin ;
Huang, Caiqun ;
Lyu, Lei ;
Hu, Bin ;
Sun, Wei ;
Duan, Yinong .
CELL DEATH & DISEASE, 2016, 7 :e2315-e2315
[5]   Research Progress on NK Cell Receptors and Their Signaling Pathways [J].
Chen, Yingying ;
Lu, Dan ;
Churov, Alexey ;
Fu, Rong .
MEDIATORS OF INFLAMMATION, 2020, 2020
[6]   Metabotropic Glutamate Receptor 5 in Natural Killer Cells Attenuates Liver Fibrosis by Exerting Cytotoxicity to Activated Stellate Cells [J].
Choi, Won-Mook ;
Ryu, Tom ;
Lee, Jun-Hee ;
Shim, Young-Ri ;
Kim, Myung-Ho ;
Kim, Hee-Hoon ;
Kim, Ye Eun ;
Yang, Keungmo ;
Kim, Kyurae ;
Choi, Sung Eun ;
Kim, Won ;
Kim, Seok-Hwan ;
Eun, Hyuk Soo ;
Jeong, Won-Il .
HEPATOLOGY, 2021, 74 (04) :2170-2185
[7]   Inhibition of NK cell activity through TGF-β1 by down-regulation of NKG2D in a murine model of head and neck cancer [J].
Dasgupta, S ;
Bhattacharya-Chatterjee, M ;
O'Malley, BW ;
Chatterjee, SK .
JOURNAL OF IMMUNOLOGY, 2005, 175 (08) :5541-5550
[8]   Hepatic NK cells attenuate fibrosis progression of non-alcoholic steatohepatitis in dependent of CXCL10-mediated recruitment [J].
Fan, Yuting ;
Zhang, Wendi ;
Wei, Haiming ;
Sun, Rui ;
Tian, Zhigang ;
Chen, Yongyan .
LIVER INTERNATIONAL, 2020, 40 (03) :598-608
[9]   Invariant natural killer T cells: Not to be ignored in liver disease [J].
Gan, Jian ;
Mao, Xiao Rong ;
Zheng, Su Jun ;
Li, Jun Feng .
JOURNAL OF DIGESTIVE DISEASES, 2021, 22 (03) :136-142
[10]  
Gao Bin, 2007, Expert Rev Gastroenterol Hepatol, V1, P173, DOI 10.1586/17474124.1.1.173